Nuvilex, Inc. announces that Legacy Biotechnologies, Inc., its joint venture partner with Reme-Flu™, reports during a May 2009 outbreak of Mexican Flu, a small group of medical doctors successfully treated several cases by employing homeopathic remedies.
Nuvilex, Inc. announces Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™, received its National Drug Code numbers from the Food and Drug Administration for its homeopathic flu remedy.
Nuvilex, Inc. (OTC BB: NVLX) Interview with Martin Schmieg, CEO
Standard Podcast:
Play Now |
Play in Popup
Nuvilex, Inc. (OTC BB: NVLX) Interview with Martin Schmieg, CEO
Standard Podcast [12:18m]:
Play Now |
Play in Popup
